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Background. Peripheral edema, in combination with severe
proteinuria and low serum albumin levels, is pathognomonic of
the nephrotic syndrome, yet the exact mechanism of its formation
is unknown. Two of the most important of the factors in Starling’s
forces controlling fluid filtration across the capillary have hitherto
not been studied in nephrotic subjects.
Methods. The hydrostatic capillary pressure at the finger nail-
fold in actively nephrotic subjects and age and sex matched
controls was studied, using direct puncture of the apex of the
capillary under video microscopy, and a servonulling apparatus to
give a direct measurement of capillary pressure. Capillary filtra-
tion capacity (CFC) at the calf was measured noninvasively by a
modern derivative of the technique of mercury strain gauge
plethysmography. Fifteen nephrotic subjects with a variety of
underlying pathological lesions, and age matched controls were
studied.
Results. Contrary to the assumption of the “overflow” hypoth-
esis of edema formation, there was no evidence of capillary
hypertension. The capillary pressure showed no difference be-
tween nephrotic subjects and controls: median (range) of 17.6
(12.0 to 24.2) compared with 17.3 (9.0 to 21.6) mm Hg, P 5 NS.
CFC was significantly higher in nephrotic subjects than controls
[5.23 (3.28 to 8.52) 3 1023 versus 3.55 (2.43 to 5.28) 3 1023
ml/min/100 g/mm Hg, P , 0.01].
Conclusions. An increase in CFC provides a potentially novel
mechanism contributing at least in part to the formation of
peripheral edema in the nephrotic syndrome.
The mechanisms of edema formation in the nephrotic
syndrome are not resolved at a microvascular level. The
early underfill theory suggested a physiological process of
renal salt and water retention, secondary to hypovolemia
from reduced serum colloid osmotic pressures due to
hypoalbuminemia [1]. The stimulus for edema formation
would initially be low serum oncotic pressure and subse-
quently salt and water overload [2]. However, an alterna-
tive “overflow” hypothesis was developed based on the
findings in several studies that plasma volume is not
necessarily reduced, and indeed is normal or elevated in the
majority of subjects [3]. In addition, renal sodium and water
handling mechanisms have been shown to be impaired in
the nephrotic state in experimental models [4], and humans
[5]. The “overflow” hypothesis regards the primary intra-
renal deficits in sodium/water excretion to be causing fluid
retention, a tendency towards increased plasma volume,
and overflow edema formation [6, 7]. At a microvascular
level, an increase in capillary hydrostatic pressure is hy-
pothesized as the factor causing extravascular fluid accu-
mulation and edema formation.
Microvascular fluid exchange is governed by the so-called
Starling’s forces. Expressed in equation form for a single
capillary the flow of fluid across the capillary wall, a
semi-permeable membrane, is related to the balance of
hydrostatic and oncotic forces acting across the capillary.
Jv 5 LpS {(Pc 2 Pi) 2 s(pp 2 pi)}
where Jv is the fluid flux or net rate of fluid movement, Lp
is the hydraulic conductivity and S the surface area of the
capillary wall; LpS is hydraulic conductance; s is the
reflection coefficient for protein; Pc and Pi are the capillary
and interstitial hydrostatic pressures, respectively; and pp
and pi are the osmotic pressures of plasma and interstitial
fluid, respectively.
The Starling equation applies to a single short section of
capillary. For a whole organ, including human limbs, the
capillary filtration coefficient or capacity (CFC) represents
the sum of the product of the average hydraulic conductiv-
ity of the walls of the exchange vessels within the tissue and
their total exchange area S(LpS) [8].
A number of the factors in this equation have been
measured in the nephrotic state. Colloid osmotic pressure
of plasma and interstitial fluid drops in parallel until
profoundly low levels of serum albumin are reached, an
important anti-edema mechanism [9]. Interstitial hydro-
static pressure was elevated in edematous areas as would be
expected [10]. However, the rate limiting factor for micro-
vascular fluid exchange, capillary filtration capacity, has not
been measured, nor has capillary hydrostatic pressure.
The currently favored overflow theory suggests an ele-
vated capillary hydrostatic pressure as the driving force
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resulting in peripheral edema formation. Alternatively,
systemic changes in capillary permeability to water [11] and
albumin [12] have been postulated in the nephrotic syn-
drome, with increased peripheral transcapillary escape
rates or gastrointestinal loss of albumin [13]. The aims of
the present study were (1) to test the overflow hypothesis,
that the capillary hydrostatic pressure of peripheral capil-
laries is increased in the nephrotic syndrome; (2) to test the
hypothesis that peripheral capillary fluid leakiness is in-
creased in the nephrotic syndrome; and (3) to assess
whether capillary pressure and capillary filtration capacity
are altered by diuretic therapy.
METHODS
Fifteen subjects (8 females, aged 21 to 79 years) were
recruited. All were clinically and biochemically nephrotic
with varying degrees of edema. Details of subjects and
controls are given in Table 1. Underlying renal pathologies
were as follows: three minimal change glomerulonephritis
(MCGN), one later developing focal segmental glomerulo-
sclerosis (FSGS), four membranous glomerulonephritis,
one myeloma, two amyloid, three proliferative glomerulo-
nephritis, one light chain disease, and one undiagnosed
(failed renal biopsy). Capillary pressure was measured in
eight subjects, the estimation not being possible in the
remainder because of: poorly visible capillaries (N 5 1);
Raynaud’s phenomenon, which may have a confounding
influence on capillary pressure (N 5 2); or inability to
schedule the examination before commencing disease mod-
ifying treatment (N 5 4). Control subjects were matched
for age (6 5 years), sex and in the case of premenopausal
females, menstrual cycle phase. Controls for capillary pres-
sure studies were also matched for nailfold skin tempera-
ture as capillary pressure is known to be related to this
variable.
Subjects were asked to refrain from taking caffeine or
smoking for two hours before the tests. Investigations took
place in a resting supine position in a temperature con-
trolled environment (22 6 1°C) after acclimatizing supine
for 30 minutes. Brachial arterial blood pressure was deter-
mined from five measurements by an automated blood
pressure recorder (Dynamap 845; Critcon Inc., Tampa, FL,
USA) and skin temperature measured at the finger nailfold
or calf by thermocouple (Fluke 52; RS Components, Corby,
UK). Capillary pressure and filtration coefficient measure-
ments were undertaken at separate times but under the
same experimental conditions.
Ten patients were treated with loop diuretics that were
omitted on the day of study. One nephrotic patient had
received a short course of nifedipine and this was discon-
tinued two days before study. The group of patients in
whom capillary pressure measurements were made did not
contain any with a diagnosis of amyloid, myeloma or light
chain disease.
The study was approved by the local Medical Research
Ethics Committee and participants gave written informed
consent.
Measurement of capillary pressure
The method of capillary pressure measurement has been
described in detail elsewhere [14]. Briefly, a scalpel blade
was used to carefully remove the upper dead layer of
opaque stratum corneum from two fingers of the left hand
without inducing bleeding or inflammation. The finger
under study was held in a plasticine mould to minimise
movement and a Granuflex ring (Squibb, Hounslow, Mid-
dlesex, UK) placed around the nailfold to retain a pool of
0.9% saline to aid visualization of the capillary and mea-
surement of atmospheric pressure. Nailfold capillary pres-
sure was measured following direct cannulation of the apex
of the capillary loop by glass micropipette held in a
micromanipulator. An electronic resistance feedback ser-
vonulling system allowed dynamic pressure recording,
Table 1. Characteristics of nephrotic subjects and controls. Results are expressed as median (range)
All nephrotic
patients Controls P
Nephrotic patients with
capillary pressure
measurement
Controls for capillary
pressure group P
Female/male number 8/7 8/7 2/6 2/6
Age years 57 (21–79) 56 (21–77) NS 53 (27–69) 57 (27–70) NS
Body mass index kg/m2 27 (23–34) 24 (20–35) NS 27 (23–34) 23 (19–32) NS
Mean arterial pressure
mm Hg
103 (77–131) 104 (86–124) NS 102 (98–131) 97 (91–122) NS
24 Hour urinary protein g 7.1 (3.8–22.4) — 7.1 (3.8–22.4) —
Urine protein/creatinine ratio — 67 (38–125) —
NR 0–125
Serum creatinine 142 (64–604) 79 (70–120) ,0.01 143 (64–280) 86 (77–110) ,0.05
NR 45–120 mmol/liter
Serum albumin 24 (15–29) 41 (38–44) ,0.01 24 (17–29) 40 (35–44) ,0.01
NR 30–48 g/liter
Time edematous weeks 8 (1–24) None 8 (2–20) None
Diuretics 10 None 6 None
Abbreviations are: NR, normal range; NS, not significant.
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which was filtered, digitized and stored on computer for
later off-line analysis.
Previous work has shown capillary pressure determina-
tions to be highly reproducible both between capillaries
across the nailfold (coefficient of variation 5.4%) in nine
capillaries measured at the same visit in five individuals,
and within the same individual over time (coefficient of
variation 9.6%) for six measurements over six months [15].
For capillary pressure studies, previous control population
data have shown a population SD for capillary pressure of
2.5 mm Hg. Based on this 16 subjects in each group would
be required to have a 90% power to show a 3 mm Hg
difference in capillary pressure between groups at a signif-
icance level of 5%. The capillaries of the finger nailfold
belong to the same class of continuous capillaries as found
in skin, connective tissues and skeletal muscle. Develop-
mentally this area is an outgrowth of the dorsal skin of the
hand. During the measurements pitting edema was ob-
served in the tissues of the distal phalanx of adjoining
fingers. Nevertheless, it is important not to assume that the
measurements of the capillary pressure at the finger nail-
fold are necessarily representative of all edema forming
regions.
Measurement of capillary filtration capacity
Mercury-in-silastic strain gauge plethysmography was
used to measure calf capillary filtration capacity (CFC), as
described by Gamble, Gartside and Christ [16]. This
method measures changes in calf volume in response to a
series of small pressure increments in a thigh occlusion
cuff. The technique has a number of theoretical advantages
over single step techniques [8]. A multiple inlet thigh
occlusion cuff was rapidly inflated by electric pump, with
pressure regulated by a multiple resistance air bleed valve.
Serial pressure increments of 8 to 12 mm Hg were made at
five minute intervals to increase lower limb venous pres-
sure. Calf swelling rate was recorded by a mercury-in-
silastic strain gauge mounted in a temperature compensat-
ing holder applied to the upper calf. Once ambient venous
pressure was exceeded, each increase in cuff pressure
produced a characteristic response. This comprised an
initial rapid calf volume increase, which was due to filling of
capacitance vessels (the venous compliance) and could be
modeled with a negative exponential curve with a time
constant of approximately 15 seconds. The concurrent
linear phase to the response reflected the fluid flux across
the capillary bed. Traces were recorded on microcomputer
for later analysis. Values for fluid flux were obtained from
the gradient of the linear phase of each volume response
curve at a period greater than five time constants from the
increase in cuff pressure. The slope of the regression line of
fluid flux and corresponding cuff pressure was calculated to
give the CFC. The horizontal intercept was the isovolumet-
ric venous pressure (Pvi), defined as the pressure at which
there was neither net fluid filtration nor absorption at the
microvascular wall. Although no net filtration was taking
place, this did not preclude simultaneous movement of
fluid into and out of the capillary. Calf tissue compliance
was calculated from the gradient of the regression line of
the venous compliance volumes plotted against cuff pres-
sure.
Using this technique to measure capillary filtration coef-
ficient in four normal individuals, studied four to six times
over 10 months, the mean intra-individual coefficient of
variation was 9.1 6 5.6% (mean 6 SD) and for Pvi was
10.7 6 4.7%.
Statistical analysis
Data are presented in the text as median (range),
assuming a non-parametric distribution. Comparison be-
tween groups was made using Mann-Whitney U-test. Cor-
relations were examined by the two-tailed Spearman rank
test.
RESULTS
Capillary pressure showed no difference between ne-
phrotic subjects and controls: 17.6 (12.0 to 24.2) compared
with 17.3 (9.0 to 21.6) mm Hg, P 5 NS (Fig. 1). CFC was
significantly higher in nephrotic subjects than controls: 5.23
(3.28 to 8.52) 3 1023 versus 3.55 (2.43 to 5.28) 3 1023
Fig. 1. Capillary pressure in patients with nephrotic syndrome and age-
and sex-matched controls. P 5 NS.
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ml/min/100 g/mm Hg, P , 0.01 (Fig. 2). Pvi was significantly
lower in nephrotic subjects 14.0 (1.8 to 38.4) versus 24.9
(17.7 to 35.6) mm Hg P , 0.01. Calf tissue compliance 5.3
(2.8 to 7.1) 3 1022 versus 4.1 (2.5 to 10.2) ml/mm Hg and
mean arterial blood pressure 102 (77 to 131) versus 104 (86
to 124) mm Hg were the same for both groups (P 5 NS).
CFC results for the nondiuretic treated subgroup alone
showed this group to have a significantly higher results
compared to their respective age and sex matched controls:
5.17 (4.04 to 6.84) 3 1023 versus 2.92 (2.63 to 4.02) 3 1023
ml/min/100 g/mm Hg, P , 0.05. CFC for the diuretic
treated subgroup was 5.52 (3.28 to 8.52) 3 1023 ml/min/100
g/mm Hg. Excluding subjects with myeloma, amyloid or
light chain disease, nephrotic subjects had a CFC of 5.18
(3.20 to 8.14) 3 1023, and controls of 3.55 (2.63 to 5.28) 3
1023 (P , 0.01). There was no significant difference
between capillary pressure in this subgroup and their
controls, or any significant correlation at a level of signifi-
cance of 5% between serum albumin concentration or
urinary albumin loss and CFC or capillary pressure. There
were no evident differences in microvascular parameters
between the groups of nephrotic subjects with different
histological diagnoses, neither was there any correlation
between CFC and renal function as measured by serum
creatinine concentrations.
DISCUSSION
This study has demonstrated an increase in calf capillary
filtration capacity in patients with active nephrotic syn-
drome, as demonstrated by a multi-step strain gauge pleth-
ysmography technique, providing a novel explanation for
edema formation in this condition. There was no difference
in finger nailfold capillary pressure in the subset in whom
measurement was possible, a finding that is at odds with the
overflow theory of edema formation.
Cardiac edema is typically associated with central venous
pressure elevation and the traditional model of the patho-
genesis suggests that the principal change in Starling’s
forces is an elevation of capillary hydrostatic pressure.
Indeed, in established peripheral edema states of acute
nephritis and cardiac failure [17, 18] finger nailfold capil-
lary pressure has been shown to be significantly elevated,
albeit with a less accurate method. It is possible that
nephrotic patients with severely diminished renal function
and hypertension might have elevated capillary pressures.
In the nephrotic syndrome two models of edema formation
have evolved. The underfill model assumes intravascular
depletion due to fluid flux from plasma caused by depleted
plasma oncotic pressure. The relative hypovolemia pro-
duced would stimulate a secondary, physiological, renal
fluid retention. This hypothesis has been disputed because
of lack of agreement in studies of plasma volume, as
summarized by Dorhout Mees, Geers and Koomans [3].
More recently, generalized salt and water overload has
been attributed to an intrinsic renal defect causing fluid
retention (overflow model), and an increase in capillary
hydrostatic pressure has been proposed to explain the
production of peripheral edema.
Referring back to the Starling equation, the microvascu-
lar basis of edema formation can be considered from
changes of the various forces. Our data suggest that,
contrary to the overflow theory, an elevation of capillary
pressure was not involved in edema formation at least at
the time of study, although it could be argued that in the
current study patients were examined at a time of re-
established steady state equilibrium, with edema accumu-
lation at an end. This would be compatible with normal
capillary pressure, but only if other factors were abnormal
to maintain the edematous state. Increased fluid flux across
the capillary due to increased hydraulic conductance, in
keeping with our findings, could contribute both to forma-
tion and maintenance of peripheral edema. Plasma and
interstitial colloid osmotic pressures (pp and pI) fall in
parallel as a function of dilution and washout in the
interstitium [9], and hence would not contribute to edema.
Interstitial pressure (Pi) is known to have a nonlinear
relationship with interstitial volume [19], and for the degree
of edema seen in the subjects described here the interstitial
pressure would be expected to be elevated from the normal
mildly negative pressures described in most subcutaneous
Fig. 2. Capillary filtration capacity in patients with nephrotic syndrome
and age- and sex-matched controls. P , 0.01.
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tissues and species examined [20]. This, and the limited
compliance of the interstitium found in the early stages of
edema formation, provide an anti-edema mechanism. This
would oppose fluid flux due to the increased CFC observed
in the present study, once the level of edema has reached a
steady state. Only after the orientation of the interstitial
proteoglycan structures has been deranged by significant
volume increase does the pressure volume curve adopt a
flat alignment and present relatively less impediment to
fluid flux from the capillary. Specific impairment of lym-
phatic drainage exacerbates the edema rather than being
the primary cause [21].
The possibility of a circulating factor altering peripheral
capillary permeability in renal disease could be hypothe-
sized. Various factors largely peculiar to MCNS or the
related FSGS, such as an altered charge on albumin and
erythrocytes [22, 23], have implications for capillary func-
tion. Circulating factors affecting glomerular permeability
have been proposed for some time [24]. Serum or plasma
from patients with focal segmental glomerulosclerosis
(FSGS) have produced proteinuria in animal models [25],
and plasma protein adsorption decreases proteinuria in
recurrent disease after renal transplantation [26]. Vascular
permeability factor (vascular endothelial growth factor) is a
disulfide-linked dimeric glycoprotein of about 40 kD that
promotes fluid and protein leakage from blood vessels [27].
It has become a candidate agent in changes of glomerular
and possibly systemic permeability in the nephrotic syn-
drome, but it appears to be implicated predominately in
minimal change nephrotic syndrome (MCNS) and possibly
IgA nephropathy [28, 29]. Few studies discuss these factors
with regard to other renal pathologies, but those that do
tend to consider nephrotic syndrome secondary to MCNS
and/or FSGS as a separate entity to other nephrotic states
[25]. Our study shows no clear trend in the small number of
subjects with minimal change disease. A unifying hypothe-
sis of circulating agent(s) altering vascular permeability in
the nephrotic state remains unproven at present.
With regards to methodology, the changes in CFC
observed in our study imply an alteration of capillary
hydraulic conductivity, or of the functional capillary surface
area available for exchange. Back perfusion of all available
capillaries in this technique due to venous distension would
argue against an increased capillary surface area being an
explanation of the findings [16], although the surface area
for exchange may not be identical to the number of
perfused capillaries: for example, there may be an increase
in membrane porosity per unit surface area of capillary
wall. Hence, both the effective area of exchange and Lp are
subject to variation. While there is no evidence of increased
total capillary surface area in the lower limb of nephrotic
subjects, such an increase cannot be ruled out. The pres-
ence of edema in the limb being measured would decrease
the ratio of capillary volume/tissue volume that might result
in an underestimation of CFC due to a proportionately
smaller capillary surface area per unit volume than in a
nonedematous state. The assessment of dry weight in
edematous nephrotic subjects is complicated by the under-
lying loss of dry body wt [3], probably due largely to loss of
muscle mass. This would increase the ratio of other tissues,
including bone, to the muscle capillary bed and tend to
result in an underestimation of CFC, independent of
changes in hydraulic conductance. As both factors may lead
to underestimates of CFC, they cannot explain our findings
of an increase in CFC in the nephrotic individuals. How-
ever, they do raise the possibility that our values may
underestimate the true values.
Diuretics have been implicated in alteration of albumin
permeability in a rat model [30]. It is unknown whether the
use of loop diuretics in human subjects alters peripheral
vascular leakiness. Ten of the subjects in this study had
ingested loop diuretics by mouth the day before the tests. It
was felt unethical to omit them for a longer period before
study in patients with active and significant fluid retention.
Nevertheless, analyzing the CFC results for the nondiuretic
treated subgroup alone shows this group to have a signifi-
cantly higher results compared to their respective age and
sex matched controls. A number of the nephrotic subjects
had renal impairment, shown by an elevated serum creati-
nine concentration. However, there was no correlation
between serum creatinine and CFC. The possibility of
comparison with subjects with impaired renal function
(rather than normal control subjects) was addressed. The
possibility of introducing other factors that might effect
endothelial function such as hypertension, medications and
underlying renal disorders, as well as uremia per se was felt
to be too great to use such a control group. In fact, the
degree of dysfunction present in the nephrotic subjects may
not be as high as suggested by the data in Table 1: only two
subjects had a serum creatinine greater than 200 mmol/liter.
In conclusion, active nephrotic syndrome is associated
with an increase in systemic CFC, providing a potentially
novel mechanism for the edema formation characteristic of
this condition. In contrast, no evidence for capillary hyper-
tension was obtained. We are unable to exclude the possi-
bility that an elevation in capillary pressure may play a role
in the initiation of edema formation; further studies are
required to delineate the relative importance of these
microvascular parameters at different stages of the disease
process.
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